Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals Announces Financial Calendar for 2015
DGAP-News: Veloxis Pharmaceuticals A/S 16.12.2014 / 13:40 --------------------------------------------------------------------- Company Announcement no. 27/2014 To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 16 December 2014 Veloxis Pharmaceuticals Announces Financial Calendar for 2015 Veloxis Pharmaceuticals A/S (OMX: VELO) today announced financial calendar for 2015. 4. March, 2015: Release of Annual Report 2014. 26 March, 2015: Annual General Meeting. 20 May, 2015: Interim Report for the 1st Quarter ‐ for the period 1 January to 31 March, 2015. 26 August, 2015: Interim Report for the 2nd Quarter - for the period 1 January to 30 June, 2015. 11 November, 2015: Interim Report for the 3rd Quarter - for the period 1 January to 30 September, 2015. For more information, please contact: Veloxis Pharmaceuticals A/S Bill Polvino Johnny Stilou President & CEO EVP, Chief Financial Officer Mobile: +1 917 647 9107 Mobile: +45 21 227 227 Email: wjp@veloxis.com Email: jst@veloxis.com About Veloxis Pharmaceuticals Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis' unique, patented delivery technology, MeltDose(R), is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO. For further information, please visit www.veloxis.com. News Source: NASDAQ OMX --------------------------------------------------------------------- 16.12.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Veloxis Pharmaceuticals A/S Denmark ISIN: DK0060048148 End of News DGAP News-Service --------------------------------------------------------------------- 306015 16.12.2014
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden